Annual Operating Profit
$12.63 M
+$55.48 M+129.48%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual operating income is $12.63 million, with the most recent change of +$55.48 million (+129.48%) on December 31, 2023.
- During the last 3 years, RDHL annual operating profit has risen by +$76.32 million (+119.84%).
- RDHL annual operating profit is now at all-time high.
Performance
RDHL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
N/A
June 1, 2024
Summary
- RDHL quarterly operating income is not available.
Performance
RDHL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
N/A
June 1, 2024
Summary
- RDHL TTM operating income is not available.
Performance
RDHL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RDHL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +129.5% | - | - |
| 3 y3 years | +119.8% | - | - |
| 5 y5 years | +132.1% | - | - |
RDHL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.6% | ||||
| 5 y | 5-year | at high | +115.6% | ||||
| alltime | all time | at high | +115.6% |
RedHill Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $12.63 M(-129.5%) | - | - |
| Jun 2023 | - | -$47.40 M(-263.0%) | -$35.38 M(-1334.8%) |
| Mar 2023 | - | $29.08 M(-392.3%) | $2.87 M(-106.7%) |
| Dec 2022 | -$42.84 M(-47.2%) | -$9.95 M(+40.0%) | -$42.84 M(-20.1%) |
| Sep 2022 | - | -$7.11 M(-22.4%) | -$53.59 M(-16.1%) |
| Jun 2022 | - | -$9.16 M(-44.9%) | -$63.88 M(-19.8%) |
| Mar 2022 | - | -$16.63 M(-19.7%) | -$79.61 M(-1.9%) |
| Dec 2021 | -$81.14 M(+27.4%) | -$20.70 M(+19.0%) | -$81.14 M(+1.2%) |
| Sep 2021 | - | -$17.40 M(-30.1%) | -$80.14 M(+3.8%) |
| Jun 2021 | - | -$24.89 M(+37.1%) | -$77.21 M(+19.1%) |
| Mar 2021 | - | -$18.15 M(-7.9%) | -$64.82 M(+1.8%) |
| Dec 2020 | -$63.68 M(+47.4%) | -$19.71 M(+36.3%) | -$63.68 M(+14.3%) |
| Sep 2020 | - | -$14.46 M(+15.7%) | -$55.74 M(+9.0%) |
| Jun 2020 | - | -$12.50 M(-26.5%) | -$51.12 M(+0.2%) |
| Mar 2020 | - | -$17.02 M(+44.6%) | -$51.00 M(+18.1%) |
| Dec 2019 | -$43.20 M(+9.8%) | -$11.76 M(+19.5%) | -$43.20 M(+4.1%) |
| Sep 2019 | - | -$9.84 M(-20.5%) | -$41.48 M(+0.3%) |
| Jun 2019 | - | -$12.38 M(+34.4%) | -$41.37 M(+7.3%) |
| Mar 2019 | - | -$9.21 M(-8.3%) | -$38.55 M(-2.0%) |
| Dec 2018 | -$39.33 M(-24.3%) | -$10.04 M(+3.2%) | -$39.33 M(-9.9%) |
| Sep 2018 | - | -$9.74 M(+1.9%) | -$43.65 M(-8.8%) |
| Jun 2018 | - | -$9.56 M(-4.4%) | -$47.88 M(-7.7%) |
| Mar 2018 | - | -$9.99 M(-30.4%) | -$51.87 M(-0.2%) |
| Dec 2017 | -$51.97 M | -$14.37 M(+2.9%) | -$51.97 M(+11.5%) |
| Sep 2017 | - | -$13.96 M(+3.1%) | -$46.60 M(+13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$13.54 M(+34.0%) | -$41.09 M(+18.3%) |
| Mar 2017 | - | -$10.10 M(+12.3%) | -$34.74 M(+13.7%) |
| Dec 2016 | -$30.54 M(+38.8%) | -$8.99 M(+6.4%) | -$30.54 M(+7.9%) |
| Sep 2016 | - | -$8.45 M(+17.5%) | -$28.32 M(+15.8%) |
| Jun 2016 | - | -$7.19 M(+21.9%) | -$24.45 M(+5.6%) |
| Mar 2016 | - | -$5.90 M(-12.7%) | -$23.15 M(+5.2%) |
| Dec 2015 | -$22.00 M(+106.6%) | -$6.76 M(+47.3%) | -$22.00 M(+9.7%) |
| Sep 2015 | - | -$4.59 M(-22.0%) | -$20.05 M(-2.0%) |
| Jun 2015 | - | -$5.89 M(+23.9%) | -$20.47 M(+9.5%) |
| Mar 2015 | - | -$4.75 M(-1.2%) | -$18.69 M(+75.6%) |
| Dec 2014 | -$10.65 M(-1.2%) | -$4.81 M(-3.9%) | -$10.65 M(+14.3%) |
| Sep 2014 | - | -$5.01 M(+21.8%) | -$9.31 M(+32.1%) |
| Jun 2014 | - | -$4.11 M(-225.0%) | -$7.05 M(+29.1%) |
| Mar 2014 | - | $3.29 M(-194.6%) | -$5.46 M(-49.3%) |
| Dec 2013 | -$10.77 M(+19.2%) | -$3.48 M(+26.6%) | -$10.77 M(+14.5%) |
| Sep 2013 | - | -$2.75 M(+8.8%) | -$9.41 M(+9.6%) |
| Jun 2013 | - | -$2.53 M(+25.2%) | -$8.58 M(+5.7%) |
| Mar 2013 | - | -$2.02 M(-4.6%) | -$8.12 M(-10.1%) |
| Dec 2012 | -$9.04 M(+14.8%) | -$2.12 M(+9.8%) | -$9.04 M(-3.7%) |
| Sep 2012 | - | -$1.93 M(-6.8%) | -$9.38 M(-3.0%) |
| Jun 2012 | - | -$2.07 M(-29.6%) | -$9.67 M(+27.2%) |
| Mar 2012 | - | -$2.93 M(+19.3%) | -$7.61 M(+62.7%) |
| Dec 2011 | -$7.87 M(+354.3%) | -$2.46 M(+11.0%) | -$4.67 M(+111.0%) |
| Sep 2011 | - | -$2.22 M | -$2.22 M |
| Dec 2010 | -$1.73 M | - | - |
FAQ
- What is RedHill Biopharma annual operating income?
- What is the all time high annual operating profit for RedHill Biopharma?
- What is RedHill Biopharma annual operating profit year-on-year change?
- What is the all time high quarterly operating profit for RedHill Biopharma?
- What is the all time high TTM operating profit for RedHill Biopharma?
What is RedHill Biopharma annual operating income?
The current annual operating profit of RDHL is $12.63 M
What is the all time high annual operating profit for RedHill Biopharma?
RedHill Biopharma all-time high annual operating income is $12.63 M
What is RedHill Biopharma annual operating profit year-on-year change?
Over the past year, RDHL annual operating income has changed by +$55.48 M (+129.48%)
What is the all time high quarterly operating profit for RedHill Biopharma?
RedHill Biopharma all-time high quarterly operating income is $29.08 M
What is the all time high TTM operating profit for RedHill Biopharma?
RedHill Biopharma all-time high TTM operating income is $2.87 M